BIO 2025

Market Access

Biotech opportunities in North Carolina, with Kyle Touchston...

From BIO 2025: Kyle Touchstone, director of Economic Development Raleigh and Laura Rowley, director of life sciences development for NCBiotech.

Digital

Interview at BIO 2025 with Hanadie Yousef

‘Insulin for muscle’ and the AI platform behind it, with Han...

R&D

Interview at BIO 2025 with Dr Joshua Hare

A regenerative approach to Alzheimer’s treatment, with Dr. J...

Patients

Phyllis Arthur, Dr Larry Buchson, Sherri Berger, and Dr Luciana Borio discuss vaccine skepticism at BIO 2025.

BIO 2025: Planning, not panic, as BIO weighs in on US vaccin...

At BIO 2025, vaccines were top of mind as a result of recent actions by HHS. Speakers addressed news head on, but also explored the larger context.

News

Amid sector disruption, biotech must focus on 'fundamentals'...

The biotech industry in the US is facing a period of deep uncertainty under the Trump administration, but can ride out the storm, says EY.

R&D

Interview at BIO 2025 with Juergen Eckhardt

Looking to early-stage companies for innovation, with Juerge...

In an interview at BIO 2025, Bayer's Juergen Eckhardt discusses the importance of external innovation and why his company is prioritising early stage.